Plant-Derived Exosomes from Gliricidia sepium for Diabetic Wound Repair: Integrating Phytochemistry and Regenerative Medicine
DOI:
https://doi.org/10.65795/5481qr83Keywords:
phytochemical analysis, Gliricidia sepium, diabetic wound healing, regenerative medicine, plant-derived, exosomes, nanoparticlesAbstract
Diabetes mellitus is a chronic disease that is becoming increasingly prevalent globally and is a major public health concern. Diabetes and its consequences have long been effectively managed and treated with extracts and compounds produced from a variety of natural resources, especially plants. The most serious co-morbidities include wounds related to diabetes mellitus, which can worsen and result in cell necrosis and amputation. 15% of diabetes patients have the disease, and 20% of them have their limb amputated, according to statistics on the condition of diabetic wounds as of late. In this review, leaf extracts from Gliricidia sepium are evaluated for their cytotoxic, wound-healing, antioxidant, and anti-diabetic qualities and combining them with the Plant-Derived Exosomes Like Nanoparticles. Studies conducted on Gliricidia sepium indicate the presence of bioactive compounds, notably phenolic compounds, steroidal compounds, polysaccharides, glycosides, alkaloid constituents, flavanoids, glycosidic triterpenes, and terpenoids. In addition to helping to prevent infections in DFUs, the plant has also shown strong antibacterial properties against harmful microorganisms. DPPH (2,2-diphenyl-1-picrylhydrazyl) radical scavenging, H2O2 radical scavenging, and reducing power tests were used to measure antioxidant activity. Suppression of α-amylase and α-glucosidase were used to evaluate the antidiabetic activity. Significant biological activities like anti–inflammatory and antimicrobial properties that promote wound healing, are displayed by Gliricidia sepium. Exosomes derived from plants have become well-known in regenerative medicine as organic nanocarriers that deliver bioactive compounds to promote tissue repair. This study emphasizes how combining cutting-edge regenerative medicine techniques using exosomes derived from plants with conventional botanical knowledge can improve therapeutic results.
Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Aneeta Joby, Thiruvengadam Subramaniyan, Rohith S, Ivo Romauld, Ezhilarasu A. (Author)

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright and Licensing
All articles published in Trends in Biomaterials and Artificial Organs are published Open Access. To ensure the widest possible dissemination of research while protecting the integrity of the original work, we utilize the Creative Commons Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) 4.0 International License.
User Rights
Under this license, the public is free to share (copy and redistribute the material in any medium or format) under the following terms:
- Attribution: Users must give appropriate credit, provide a link to the license, and indicate if changes were made.
- Non-Commercial: Users may not use the material for commercial purposes. This includes, but is not limited to, the sale of the article or its use in promotional materials for-profit.
- No Derivatives: If a user remixes, transforms, or builds upon the material, they may not distribute the modified material.
Author Rights
Authors retain copyright of their work while granting the journal a non-exclusive license to publish. Because of the NoDerivs (ND) and Non-Commercial (NC) designations:
- Third parties (such as other researchers) must seek permission from the authors/journal to include figures, tables, or portions of the text in new works or commercial publications.
- Authors may deposit the "Version of Record" in institutional repositories immediately upon publication, provided the CC BY-NC-ND 4.0 license is clearly linked.
How to Cite
Accepted 30-03-2026
Published 09-07-2026


